ProShares Ultra Health Care (RXL)

NYSEARCA: RXL · Real-Time Price · USD
40.14
-0.20 (-0.49%)
At close: Jun 27, 2025, 4:00 PM
40.14
0.00 (0.00%)
After-hours: Jun 27, 2025, 8:00 PM EDT
-0.49%
Assets $65.21M
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 1.62M
Dividend (ttm) $0.63
Dividend Yield 1.57%
Ex-Dividend Date Jun 25, 2025
Payout Ratio n/a
1-Year Return -21.64%
Volume 9,679
Open 40.31
Previous Close 40.34
Day's Range 40.02 - 40.77
52-Week Low 36.52
52-Week High 58.74
Beta 1.29
Holdings 70
Inception Date Jan 30, 2007

About RXL

Fund Home Page

The ProShares Ultra Health Care (RXL) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 2x leveraged exposure to a cap-weighted index of US health care companies. RXL was launched on Jan 30, 2007 and is issued by ProShares.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol RXL
ETF Provider ProShares
Index Tracked Health Care Select Sector

Top 10 Holdings

146.37% of assets
Name Symbol Weight
HEALTH CARE SELECT SECTOR INDEX SWAP UBS AG n/a 31.34%
HEALTH CARE SELECT SECTOR INDEX SWAP GOLDMAN SACHS INTERNATIONAL n/a 23.18%
HEALTH CARE SELECT SECTOR INDEX SWAP BANK OF AMERICA NA n/a 22.22%
HEALTH CARE SELECT SECTOR INDEX SWAP CITIBANK NA n/a 16.60%
HEALTH CARE SELECT SECTOR INDEX SWAP SOCIETE GENERALE n/a 13.86%
HEALTH CARE SELECT SECTOR INDEX SWAP BNP PARIBAS n/a 13.17%
Eli Lilly and Company LLY 10.19%
Johnson & Johnson JNJ 5.96%
AbbVie Inc. ABBV 5.38%
UnitedHealth Group Incorporated UNH 4.47%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Jun 25, 2025 $0.21928 Jul 1, 2025
Mar 26, 2025 $0.13435 Apr 1, 2025
Dec 23, 2024 $0.14718 Dec 31, 2024
Sep 25, 2024 $0.12875 Oct 2, 2024
Jun 26, 2024 $0.17268 Jul 3, 2024
Mar 20, 2024 $0.08603 Mar 27, 2024
Full Dividend History

News

ProShares and ProFunds Announce Benchmark Changes for 53 Geared Sector Funds

BETHESDA, Md.--(BUSINESS WIRE)--ProShares and ProFunds, premier providers of leveraged and inverse funds, announced plans to change the underlying indices for a combined 53 sector ETFs and mutual fu...

Other symbols: DIGDUGLTLREKREWROMRXD
2 years ago - Business Wire

Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...

4 years ago - Seeking Alpha

Healthcare: A Wide Choice Of Large And Well-Established Companies

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...

4 years ago - Seeking Alpha

RXL Is The Best Healthcare ETF Wealth-Builder Now

RXL Is The Best Healthcare ETF Wealth-Builder Now

5 years ago - Seeking Alpha